Analysts Adjust Ratings for Owens & Minor Amid Declining Targets

Owens & Minor sees mixed analyst ratings, with the average price target down significantly. Investment strategies may be influenced by the latest bearish sentiment and revenue growth.

Date: 11-03-2025

AI Rating: 4

Analyst Sentiment: Recent ratings from analysts on Owens & Minor highlight a bearish trend, with the total ratings showing a majority leaning toward indifferent or somewhat bearish. This suggests uncertainty about the company's future performance.

Price Target Insights: Analysts have adjusted their 12-month price targets drastically, with the average now at $11.6, reflecting a substantial decrease from $15.60. The high and low estimates of $14.00 and $10.00 further emphasize this downward trend.

Revenue Growth: Positively, Owens & Minor reported a revenue growth rate of 1.5% over three months, surpassing many competitors in the Health Care sector. This accomplishment could foster investor confidence despite other negative signals.

Net Margin Performance: The company boasts a net margin of -10.98%, which may indicate potential profitability issues. However, the mention of effective cost control may still attract some cautious positive sentiment.

Return on Equity (ROE): Owens & Minor's ROE stands at -41.13%, indicating that the company faces difficulties maximizing shareholder returns. Such performance can raise red flags for investors regarding the viability of their investments.

Debt Management: The debt-to-equity ratio of 3.79 is below the industry average, suggesting a conservative approach to debt financing that may be interpreted as a positive sign by investors.

Stocks: OMI